文献速递银屑病与炎症性皮肤病湿疹皮炎与荨麻疹

中和IL-17C可减轻银屑病与特应性皮炎小鼠模型的皮肤炎症

Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis.
PubMed 文献 · J Invest Dermatol · 2018-02-21

研究生成可选择性结合人与小鼠IL-17C并阻断其与IL-17RE结合的抗IL-17C抗体MOR106,在IL-23诱导的银屑病样皮肤炎症模型中抑制皮肤炎症;在特应性皮炎患者皮损中IL-17C表达升高并定位于角质形成细胞和浸润免疫细胞;在卡泊三醇诱导及flaky tail小鼠特应性皮炎模型中,MOR106抑制耳部皮肤炎症及TSLP、IL-33产生,并降低血清IgE、皮肤肥大细胞数及血清IL-4和CCL17。

要点

  • MOR106可选择性结合人与小鼠IL-17C并阻断其与IL-17RE结合。
  • MOR106在IL-23诱导的银屑病样皮肤炎症模型中抑制皮肤炎症。
  • 在两种特应性皮炎小鼠模型中MOR106减轻皮肤炎症及相关2型炎症指标。

核心结论

  • IL-17C是银屑病之外皮肤炎症的核心介质,尤其在特应性皮炎中具有相关性。

研究设计与样本

  • 研究生成抗IL-17C抗体MOR106,并在IL-23诱导的银屑病样皮肤炎症模型及两种特应性皮炎小鼠模型中测试。

主要发现

  • 在特应性皮炎患者皮损中,IL-17C表达水平升高并定位于角质形成细胞和浸润免疫细胞。
  • 在卡泊三醇诱导的特应性皮炎模型中,MOR106抑制耳部皮肤炎症以及耳部TSLP和IL-33蛋白产生。
  • 在flaky tail小鼠模型中,MOR106减少自发性特应性皮炎样皮肤炎症,并降低血清IgE水平、皮肤肥大细胞数及血清IL-4和CCL17。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IL-17C is a functionally distinct member of the IL-17 family that was believed to play a role in the pathogenesis of psoriasis. Here we confirmed that IL-17C is involved in psoriasis and explored potential roles for IL-17C in atopic dermatitis (AD). An anti-IL-17C antibody, MOR106, was generated that potently and selectively binds to human and mouse IL-17C, thereby inhibiting the binding of IL-17C to its IL-17RE receptor. The antibody inhibited cutaneous inflammation in an IL-23-induced psoriatic-like skin inflammation model. In lesional skin of patients with AD, IL-17C expression levels were increased and localized to keratinocytes and infiltrating immune cells. To determine the contribution of IL-17C to AD pathogenesis, MOR106 was tested in two distinct in vivo models. In the calcipotriol-induced AD model, ear skin inflammation, TSLP, and IL-33 protein production in ears was suppressed by MOR106. Consistently, in the flaky tail strain mouse model, spontaneous development of AD-like skin inflammation was reduced by MOR106. Moreover, serum IgE levels, number of mast cells in skin and T helper type 2-related cytokines IL-4 and CCL17 in serum were all reduced. Overall, our results indicate that IL-17C is a central mediator of skin inflammation beyond psoriasis and is relevant in particular in AD.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Vandeghinste N, Klattig J, Jagerschmidt C, et al. Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis. J Invest Dermatol. 2018. PMID: 29474945. doi:10.1016/j.jid.2018.01.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。